Merck’s Covid pill Molnupiravir was authorized for the first time in the U.K.
among those who received the drug was 7.3% compared to 14.1% of those given a placebo, Merck said.
Merck said it expects global revenue from the pill, developed by it and Ridgeback Biotherapeutics, to total up toAt home, whether the pill will receive the green light will be determined when the Food and Drug Administration meets to discuss the safety and efficacy data of molnupiravir at the end of this month.Professor Sir Munir Pirmohamed, chair of the U.K.’s Commission on Human Medicines said that Lagevrio—monulpiravir's brand name in the U.K.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
‘Covid breakthrough’: Pfizer says new drug could nearly end Covid deathsAccording to Pfizer, clinical trials show their new anti-viral drug cuts the risk of death and hospitalization in high-risk adults by 89%.
Lire la suite »
Food banks embark on expansions with lessons from COVIDATLANTA (AP) — Food banks across the country are pursuing major expansion projects driven in part by their experiences during the pandemic, when they faced an explosion of need. “So many people who had never had to ask for help found themselves in a position of needing it and not knowing where to go,” said Ginette Bott, president and CEO of the Utah Food Bank.
Lire la suite »
Moderna shares fall after company cuts 2021 forecast for Covid vaccine salesModerna shares fell Thursday after it cut its Covid-19 vaccine sales forecast for the year and missed earnings and revenue expectations for the third quarter.
Lire la suite »
U.S. life expectancy falls sharply in 'sobering' loss of young people to CovidThe United States had the second-steepest decline in life expectancy among high-income countries last year during the pandemic, according to a study of death
Lire la suite »
Several big business groups aren't happy with Biden's Covid vaccine mandateIndustry groups and unions applauded that delay and shared messages of support for vaccinations generally, but were broadly wary of the private-sector mandate.
Lire la suite »
Britain approves Merck's COVID-19 pill in world firstBritain on Thursday became the first country in the world to approve a potentially game-changing COVID-19 antiviral pill jointly developed by U.S.-based Merck and Ridgeback Biotherapeutics, in a boost to the fight against the pandemic.
Lire la suite »